A wild zebra chase

Nephrology Dialysis Transplantation

Volumn 22, Issue 10, 2007, Pages 3074-3077

  Woywodt, Alexander ^a,d   Hellweg, Susan ^b   Schwarz, Anke ^b   Schaefer, Roland M ^c   Mengel, Michael ^b  

^a LANCASHIRE TEACHING HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^b HANNOVER MEDICAL SCHOOL   (Germany)

^c UNIVERSITY OF MÜNSTER   (Germany)

^d ROYAL PRESTON HOSPITAL   (United Kingdom)

Author keywords

Anderson Fabry disease; Chloroquine; Diagnosis; Hydroxychloroquine; Iatrogenic phospholipidosis; Lysosomal storage disorder; Renal biopsy

Indexed keywords

HYDROXYCHLOROQUINE; METHOTREXATE; METOPROLOL; PREDNISOLONE; RAMIPRIL;

AGED; ANDERSON FABRY DISEASE; AORTA ATHEROSCLEROSIS; ARTICLE; BLOOD PRESSURE REGULATION; CASE REPORT; DIAGNOSTIC ACCURACY; DIAGNOSTIC REASONING; DRUG DOSE REDUCTION; DRUG WITHDRAWAL; ELECTROCARDIOGRAM; FEMALE; GENETIC ANALYSIS; GLOMERULONEPHRITIS; HUMAN; IATROGENIC DISEASE; INFORMED CONSENT; KIDNEY BIOPSY; LABORATORY TEST; LIPIDOSIS; LYSOSOME STORAGE DISEASE; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS;

AGED; BIOPSY; DIAGNOSIS, DIFFERENTIAL; FABRY DISEASE; FEMALE; HUMANS; HYDROXYCHLOROQUINE; IATROGENIC DISEASE; KIDNEY; LYSOSOMAL STORAGE DISEASES; NEPHROLOGY; PHOSPHOLIPIDS; PODOCYTES;

EID: 36048963312     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfm462     Document Type: Article

References (15)

1. Saint S, Saha S, Tierney LM, Jr. Clinical problemsolving. A square peg in a round hole. N Engl J Med 1998; 338: 379-383
2. Fabry H. An historical overview of Fabry disease. J Inherit Metab Dis 2001; 24 [Suppl 2]: 3-7
3. Gupta S, Ries M, Kotsopoulos S, Schiffmann R. The relationship of vascular glycolipid storage to clinical manifestations of Fabry disease: a cross-sectional study of a large cohort of clinically affected heterozygous women. Medicine 2005; 84: 261-268
4. Desnick RJ, Brady R, Barranger J et al. Fabry disease, an underrecognized multisystemic disorder: expert recommendations for diagnosis, management, and enzyme replacement therapy. Ann Intern Med 2003; 138: 338-346
5. Rolfs A, Bottcher T, Zschiesche M et al. Prevalence of Fabry disease in patients with cryptogenic stroke: a prospective study. Lancet 2005; 366: 1794-1796
6. Praet M, Quatacker J, Van Loo A, Vanholder R, Lameire N, Ringoir S. Non-invasive diagnosis of Fabry's disease by electronmicroscopic evaluation of urinary sediment. Nephrol Dial Transplant 1995; 10: 902-903
7. Touboul D, Roy S, Germain DP et al. Fast fingerprinting by MALDI-TOF mass spectrometry of urinary sediment glycosphingolipids in Fabry disease. Anal Bioanal Chem 2005; 382: 1209-1216
8. Hollak CE, Vedder AC, Linthorst GE, Aerts JM. Novel therapeutic targets for the treatment of Fabry disease. Expert Opin Ther Targets 2007; 11: 821-833
9. Muller-Hocker J, Schmid H, Weiss M, Dendorfer U, Braun GS. Chloroquine-induced phospholipidosis of the kidney mimicking Fabry's disease: case report and review of the literature. Hum Pathol 2003; 34: 285-289
10. Albay D, Adler SG, Philipose J, Calescibetta CC, Romansky SG, Cohen AH. Chloroquine-induced lipidosis mimicking Fabry disease. Mod Pathol 2005; 18: 733-738
11. Inagaki M, Katsumoto T, Nanba E, Ohno K, Suehiro S, Takeshita K. Lysosomal glycosphingolipid storage in chloroquine-induced alpha-galactosidase- deficient human endothelial cells with transformation by simian virus 40: in vitro model of Fabry disease. Acta Neuropathol 1993; 85: 272-279
12. Reffelmann T, Naami A, Speunrup E, Kuhl HP. Contrast-enhanced magnetic resonance imaging of a patient with chloroquine-induced cardiomyopathy confirmed by endomyocardial biopsy. Circulation 2007; 114: e357-e358
13. Bracamonte ER, Kowalewska J, Starr J, Gitomer J, Alpers CE. Iatrogenic phospholipidosis mimicking Fabry disease. Am J Kidney Dis 2006; 48: 844-850
14. Shakespeare W. Romeo and Juliet: Penguin Classics, 1981:Act II, Scene IV.
15. Romero MA, Milligan A, Briva J, Basalla D. Supporting the patient and family with Fabry disease. Acta Paediatr Suppl 2007; 96: 88-89